Literature DB >> 24763081

Long-lasting alterations in 5-HT2A receptor after a binge regimen of methamphetamine in mice.

Hong-Yi Chiu1, Ming-Huan Chan2, Mei-Yi Lee1, Shao-Tsu Chen1, Zih-Yi Zhan3, Hwei-Hsien Chen1.   

Abstract

The repeated administration of methamphetamine (MA) to animals in a single-day 'binge' dosing regimen produces damage to dopamine and serotonin terminals and psychosis-like behaviours similar to those observed in MA abusers. The present study aimed to examine the effects of MA binge exposure on 5-HT2A receptors, the subtype of serotonin receptors putatively involved in psychosis. ICR male mice were treated with MA (4 × 5 mg/kg) or saline at 2 h intervals. Recognition memory and social behaviours were sequentially evaluated by a novel location recognition test, a novel object recognition test, a social interaction and a nest-building test to confirm the persistent cognitive and behavioural impairments after this dosing regimen. Subsequently, a hallucinogenic 5-HT2A/2C receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI)-induced head-twitch, molecular and electrophysiological responses were monitored. Finally, the levels of 5-HT2C, 5-HT1A, 5-HT2A and mGlu2 receptors in the medial prefrontal cortex were determined. MA binge exposure produced recognition memory impairment, reduced social behaviours, and increased DOI-induced head-twitch response, c-Fos and Egr-2 expression and field potentials in the medial prefrontal cortex. Furthermore, MA binge exposure increased 5-HT2A and decreased mGlu2 receptor expression in the medial frontal cortex, whereas 5-HT2C and 5-HT1A receptors were unaffected. These data reveal that the increased behavioural, molecular and electrophysiological responses to DOI might be associated with an up-regulation of 5-HT2A receptors in the medial prefrontal cortex after MA binge exposure. Identifying the biochemical alterations that parallel the behavioural changes in a mouse model of MA binge exposure may facilitate targeting therapies for treatment of MA-related psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24763081     DOI: 10.1017/S1461145714000455

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  6 in total

Review 1.  Epigenetic Mechanisms of Serotonin Signaling.

Authors:  Terrell Holloway; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2015-03-10       Impact factor: 4.418

Review 2.  Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.

Authors:  Juan F López-Giménez; Javier González-Maeso
Journal:  Curr Top Behav Neurosci       Date:  2018

3.  Investigating the Role of Serotonin in Methamphetamine Psychosis: Unaltered Behavioral Effects of Chronic Methamphetamine in 5-HT1A Knockout Mice.

Authors:  Emily J Jaehne; Dzeneta Ameti; Tehani Paiva; Maarten van den Buuse
Journal:  Front Psychiatry       Date:  2017-04-20       Impact factor: 4.157

4.  An ontogenic study of receptor mechanisms by which acute administration of low-doses of methamphetamine suppresses DOI-induced 5-HT2A-receptor mediated head-twitch response in mice.

Authors:  Yina Sun; Seetha Chebolu; Denise Henry; Sandeep Lankireddy; Nissar A Darmani
Journal:  BMC Neurosci       Date:  2022-01-04       Impact factor: 3.288

5.  Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.

Authors:  Liliana Mendieta; Noelia Granado; José Aguilera; Yousef Tizabi; Rosario Moratalla
Journal:  Int J Neuropsychopharmacol       Date:  2016-08-12       Impact factor: 5.176

Review 6.  Pivotal mental states.

Authors:  Ari Brouwer; Robin Lester Carhart-Harris
Journal:  J Psychopharmacol       Date:  2020-11-11       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.